A detailed history of Northwest Bank & Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northwest Bank & Trust CO holds 9,618 shares of BMY stock, worth $540,723. This represents 0.38% of its overall portfolio holdings.

Number of Shares
9,618
Previous 9,614 0.04%
Holding current value
$540,723
Previous $399 Million 24.67%
% of portfolio
0.38%
Previous 0.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$39.66 - $51.75 $158 - $207
4 Added 0.04%
9,618 $498 Million
Q2 2024

Jul 31, 2024

SELL
$40.25 - $52.99 $25,035 - $32,959
-622 Reduced 6.08%
9,614 $399 Million
Q1 2024

May 23, 2024

BUY
$47.98 - $54.4 $5,373 - $6,092
112 Added 1.11%
10,236 $450 Million
Q4 2023

Mar 04, 2024

SELL
$48.48 - $57.85 $969 - $1,157
-20 Reduced 0.2%
10,124 $519 Million
Q2 2023

Jul 18, 2023

BUY
$63.71 - $70.74 $646,274 - $717,586
10,144 New
10,144 $649 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northwest Bank & Trust CO Portfolio

Follow Northwest Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bank & Trust CO with notifications on news.